Year: 2020
New TMPRSS2-Expressing Cell Line for COVID-19 Research
We are offering a brand new cell line to assist researchers in the fight against COVID-19.The cell line (JCRB1819), developed...
What is ADME and how does it fit into drug development?
The main aim of drug development is to get a compound that has a therapeutic effect into the form of...
COVID-19 Updates
As a global Life Sciences and Healthcare company, XenoTech recognizes the seriousness of the Coronavirus Pandemic. We are constantly monitoring...
In Vitro Evaluation of Drug-Drug Interaction (DDI) Potential
In its most recent in vitro drug interaction guidance update, the US Food and Drug Administration (FDA) emphasized harmony with the...
Four ways to optimize preclinical in vitro data to mitigate risk of late-stage clinical failure
1. Collect high-quality data to make informed, confident go/no go decisions for moving your drug candidate forward If you need...
How can in vitro and in vivo studies help me understand my drug’s clearance?
Systemic clearance, denoting how much drug is cleared from a volume of blood per unit of time, is of critical...
KC Business Journal: KCK company helps Big Pharma save money at the molecular level
Moving a new drug from lab to market is difficult, time-consuming and expensive for any size pharmaceutical or biotechnology company....
Meet the Scientist: Andrea Wolff
At XenoTech, we pride ourselves on our 3S Principles – the values and standards that guide our businesses and shape...
Timing of In Vitro Studies: Early, Thorough ADME for Your Compound’s Success
Beyond the need for evidence that a drug works, Food and Drug Administration (FDA) and other regulatory bodies around the...
Meet the Scientist: Mark Horrigan
Continuing our effort to put faces to the names of some of the scientists you interact with at XenoTech, we...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback
